399 related articles for article (PubMed ID: 25232030)
21. H2AX phosphorylation and DNA damage kinase activity are dispensable for herpes simplex virus replication.
Botting C; Lu X; Triezenberg SJ
Virol J; 2016 Jan; 13():15. PubMed ID: 26817608
[TBL] [Abstract][Full Text] [Related]
22. ATM mutation and radiosensitivity: An opportunity in the therapy of mantle cell lymphoma.
Ahmed M; Li L; Pinnix C; Dabaja B; Nomie K; Lam L; Wang M
Crit Rev Oncol Hematol; 2016 Nov; 107():14-19. PubMed ID: 27823642
[TBL] [Abstract][Full Text] [Related]
23. Effects of hydroxyurea and aphidicolin on phosphorylation of ataxia telangiectasia mutated on Ser 1981 and histone H2AX on Ser 139 in relation to cell cycle phase and induction of apoptosis.
Kurose A; Tanaka T; Huang X; Traganos F; Dai W; Darzynkiewicz Z
Cytometry A; 2006 Apr; 69(4):212-21. PubMed ID: 16528719
[TBL] [Abstract][Full Text] [Related]
24. Replication protein A2 phosphorylation after DNA damage by the coordinated action of ataxia telangiectasia-mutated and DNA-dependent protein kinase.
Wang H; Guan J; Wang H; Perrault AR; Wang Y; Iliakis G
Cancer Res; 2001 Dec; 61(23):8554-63. PubMed ID: 11731442
[TBL] [Abstract][Full Text] [Related]
25. Ionizing radiation-dependent gamma-H2AX focus formation requires ataxia telangiectasia mutated and ataxia telangiectasia mutated and Rad3-related.
Friesner JD; Liu B; Culligan K; Britt AB
Mol Biol Cell; 2005 May; 16(5):2566-76. PubMed ID: 15772150
[TBL] [Abstract][Full Text] [Related]
26. Targeting ATM and ATR for cancer therapeutics: Inhibitors in clinic.
Priya B; Ravi S; Kirubakaran S
Drug Discov Today; 2023 Aug; 28(8):103662. PubMed ID: 37302542
[TBL] [Abstract][Full Text] [Related]
27. A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments.
Mohni KN; Thompson PS; Luzwick JW; Glick GG; Pendleton CS; Lehmann BD; Pietenpol JA; Cortez D
PLoS One; 2015; 10(5):e0125482. PubMed ID: 25965342
[TBL] [Abstract][Full Text] [Related]
28. Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition.
Middleton FK; Patterson MJ; Elstob CJ; Fordham S; Herriott A; Wade MA; McCormick A; Edmondson R; May FE; Allan JM; Pollard JR; Curtin NJ
Oncotarget; 2015 Oct; 6(32):32396-409. PubMed ID: 26486089
[TBL] [Abstract][Full Text] [Related]
29. ZEB1 inhibition sensitizes cells to the ATR inhibitor VE-821 by abrogating epithelial-mesenchymal transition and enhancing DNA damage.
Song N; Jing W; Li C; Bai M; Cheng Y; Li H; Hou K; Li Y; Wang K; Li Z; Liu Y; Qu X; Che X
Cell Cycle; 2018; 17(5):595-604. PubMed ID: 29157079
[TBL] [Abstract][Full Text] [Related]
30. ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells.
Kwok M; Davies N; Agathanggelou A; Smith E; Oldreive C; Petermann E; Stewart G; Brown J; Lau A; Pratt G; Parry H; Taylor M; Moss P; Hillmen P; Stankovic T
Blood; 2016 Feb; 127(5):582-95. PubMed ID: 26563132
[TBL] [Abstract][Full Text] [Related]
31. The development of ataxia telangiectasia mutated kinase inhibitors.
Andrs M; Korabecny J; Nepovimova E; Jun D; Hodny Z; Moravcova S; Hanzlikova H; Kuca K
Mini Rev Med Chem; 2014; 14(10):805-11. PubMed ID: 25138084
[TBL] [Abstract][Full Text] [Related]
32. ATM and ATR as therapeutic targets in cancer.
Weber AM; Ryan AJ
Pharmacol Ther; 2015 May; 149():124-38. PubMed ID: 25512053
[TBL] [Abstract][Full Text] [Related]
33. Aldehyde dehydrogenase inhibitors promote DNA damage in ovarian cancer and synergize with ATM/ATR inhibitors.
Grimley E; Cole AJ; Luong TT; McGonigal SC; Sinno S; Yang D; Bernstein KA; Buckanovich RJ
Theranostics; 2021; 11(8):3540-3551. PubMed ID: 33664846
[No Abstract] [Full Text] [Related]
34. Specific Human ATR and ATM Inhibitors Modulate Single Strand DNA Formation in
da Silva RB; Bertoldo WDR; Naves LL; de Vito FB; Damasceno JD; Tosi LRO; Machado CR; Pedrosa AL
Front Cell Infect Microbiol; 2021; 11():802613. PubMed ID: 35059327
[No Abstract] [Full Text] [Related]
35. Selective human inhibitors of ATR and ATM render Leishmania major promastigotes sensitive to oxidative damage.
da Silva RB; Machado CR; Rodrigues ARA; Pedrosa AL
PLoS One; 2018; 13(9):e0205033. PubMed ID: 30265735
[TBL] [Abstract][Full Text] [Related]
36. HUS1 regulates in vivo responses to genotoxic chemotherapies.
Balmus G; Lim PX; Oswald A; Hume KR; Cassano A; Pierre J; Hill A; Huang W; August A; Stokol T; Southard T; Weiss RS
Oncogene; 2016 Feb; 35(5):662-9. PubMed ID: 25915840
[TBL] [Abstract][Full Text] [Related]
37. Lyn tyrosine kinase promotes silencing of ATM-dependent checkpoint signaling during recovery from DNA double-strand breaks.
Fukumoto Y; Kuki K; Morii M; Miura T; Honda T; Ishibashi K; Hasegawa H; Kubota S; Ide Y; Yamaguchi N; Nakayama Y; Yamaguchi N
Biochem Biophys Res Commun; 2014 Sep; 452(3):542-7. PubMed ID: 25173936
[TBL] [Abstract][Full Text] [Related]
38. Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.
Greiner TC; Dasgupta C; Ho VV; Weisenburger DD; Smith LM; Lynch JC; Vose JM; Fu K; Armitage JO; Braziel RM; Campo E; Delabie J; Gascoyne RD; Jaffe ES; Muller-Hermelink HK; Ott G; Rosenwald A; Staudt LM; Im MY; Karaman MW; Pike BL; Chan WC; Hacia JG
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2352-7. PubMed ID: 16461462
[TBL] [Abstract][Full Text] [Related]
39. Interplay between ATM and ATR in the regulation of common fragile site stability.
Ozeri-Galai E; Schwartz M; Rahat A; Kerem B
Oncogene; 2008 Apr; 27(15):2109-17. PubMed ID: 17934520
[TBL] [Abstract][Full Text] [Related]
40. The Adenovirus E4orf4 Protein Provides a Novel Mechanism for Inhibition of the DNA Damage Response.
Brestovitsky A; Nebenzahl-Sharon K; Kechker P; Sharf R; Kleinberger T
PLoS Pathog; 2016 Feb; 12(2):e1005420. PubMed ID: 26867009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
